The Best Advice You Could Ever Get About Ertugliflozin 10 MG , sitaglaptin 100 Mg Tablets

 What is Ertugliflozin

Ertugliflozin is not authorized in the European Union. Studies in adults are currently on-going. This medicine is proposed in adults for the treatment of type 2 diabetes mellitus. Ertugliflozin works by blocking a protein in the kidneys called sodium-glucose cotransporter 2 (SGLT2). SGLT2 is a protein that absorbs glucose from the urine back into the bloodstream as the blood is filtered through the kidneys. By blocking the action of SGLT2 ertugliflozin causes more glucose to be removed via the urine, thereby reducing the levels of glucose in the blood



How to Buy Ertugliflozin 

Ertugliflozin suppliers in India. Allevaire India Network New Delhi, INDIA.

Alleviare Life sciences Pvt. Ltd. is a consulting pharmaceutical company specialized in providing medicines under Named Patient Program/Manage Access Program. Named Patient Program/ Manage Access Program is a program designed by the government of India and governments of many countries worldwide for patients who have exhausted the treatment options available in their respective countries and are in need of latest medicines that are available in countries of Europe and USA.

The order for Ertugliflozin will be confirmed only after the receipt 

of valid prescription of doctor and import permit if applicable.


What are The use of Ertugliflozin 

Ertugliflozin 10 MG , sitaglaptin 100 Mg Tablets is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems


What are the facts of Ertugliflozin 

Medicine Name: Ertugliflozin

Approval Date: May 20, 2013

Company Name: Merck & Co., Inc. and Pfizer


Dosage Forms and Strength Ertugliflozin 

Available as (Form & Strength): Tablets: 5 mg and 10 mg.



Comments

Post a Comment

Popular posts from this blog

What Is IDHIFA (Enasidenib)? Causes, Side Effects, Dosage

Image
  WHAT IS IDHIFA (Enasidenib)? IDHIFA Medicine IDHIFA is a prescription medicine used to treat people with acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation whose disease has come back or has not improved after previous treatment(s). It is not known if IDHIFA is safe and effective in children. IDHIFA may cause serious side effects, including: Differentiation Syndrome. Differentiation syndrome is a condition that affects your blood cells which may be life-threatening or lead to death if not treated. Differentiation syndrome has happened within 1 day and up to 5 months after starting IDHIFA. Check the following symptoms below. ·          fever ·          cough ·          shortness of breath ·          swelling of arms and legs ·          fast weight gain (greater than 10 pounds within a week) ·          bone pain If you develop any of these symptoms of differentiation syndrome, your healthcare provider may start you on a medicine taken by m
Read more

Hunter Syndrome is Very Rare | Named Patient Program in India

Image
  Hunter Syndrome is an extremely uncommon, acquired hereditary problem brought about by an absent or breaking down compound. In Hunter disorder, the body needs more of the compound iduronate 2-sulfatase. This present compound's responsibility is to separate specific complex particles, and without enough of this protein, the atoms develop in unsafe sums.  The development of enormous measures of these unsafe substances in the long run causes long-lasting, moderate harm influencing appearance, mental turn of events, organ work and actual capacities. Hunter Syndrome is undeniably more normal in young men. The condition is one kind of a gathering of acquired metabolic issues called mucopolysaccharidoses (MPSs). Tracker condition is otherwise called MPS II. Import Elaprase (idursulfase) medicine under named patient program which is commonly use for hunter syndrome.  There's no remedy for Hunter disorder. Treatment includes overseeing side effects and difficulties. Side effects Syndr
Read more

Glyxambi (empagliflozin and linagliptin) Medicine - Uses, Precautions, Indications

Image
What is Glyxambi? Glyxambi (empagliflozin and linagliptin) is a combination of an inhibitor of the sodium-glucose co-transporter (SGLT2) and an inhibitor of the dipeptidyl peptidase-4 (DPP-4) enzyme as an adjunct to diet and exercise to improve glycemic control. What are the side effects of Glyxambi? Common side effects of Glyxambi include: • urinary tract infection • Common cold symptoms • Upper respiratory tract infection • Genital Yeast Infection • Increased urination • Joint pain • Nausea • runny or stuffy nose • Diarrhea • cough • Elevated blood cholesterol or fat • Diarrhea Glyxambi Dosage The recommended dose of Glyxambi is 10 mg empagliflozin/5 mg linagliptin, taken once daily in the morning, with or without food. In patients who tolerate Glyxambi, the dose may be increased to 25 mg empagliflozin/5 mg linagliptin once daily. Do drugs, substances, or supplements interact with Glyxambi? Glyxambi during pregnancy and lactation During pregnancy
Read more